Flagship explainer
How AYTU BIOPHARMA, INC makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $66.4M | 100% |
| |
| Cost of revenue | $20.6M | 31% |
|
| $45.8M | 69% |
| |
| −$7.8M | −12% |
| |
| Income before tax | −$13.7M | −21% |
|
| Income tax | $437000 | 1% |
|
| −$13.6M | −20% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001437749-25-029723